Cargando…
THU456 Beyond Guidelines: Treatment Of Concurrent Osteogenesis Imperfecta And Metastatic Bone Disease
Disclosure: M. Kanin: None. M. Lechner: None. Introduction: Osteogenesis imperfecta (OI) is a rare inherited skeletal dysplasia characterized by bone fragility and skeletal malformation predisposing patients to multiple, recurrent fractures. Treatment of OI is challenging and requires a multidiscipl...
Autores principales: | Kanin, Maralee, Lechner, Melissa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10555071/ http://dx.doi.org/10.1210/jendso/bvad114.417 |
Ejemplares similares
-
THU455 Sclerostin Inhibitor Use In The Medical Management Of Osteogenesis Imperfecta Type III
por: Lundholm, Michelle Diane, et al.
Publicado: (2023) -
Osteogenesis Imperfecta With Cerebral Atherosclerosis: A Family Report
por: He, Junyu, et al.
Publicado: (2021) -
Lung Transplantation in a Patient With Osteogenesis Imperfecta and Osteoporosis
por: Fan, Lena, et al.
Publicado: (2021) -
SUN-LB66 Oral Risedronate Treatment in Children With Osteogenesis Imperfecta
por: Nguyen, Antoine T, et al.
Publicado: (2020) -
OR13-5 The Molecular Landscape of Osteogenesis Imperfecta in a Brazilian Tertiary Service Cohort
por: Simões, Vivian Roberta, et al.
Publicado: (2019)